The experience of every cancer patient is a powerful legacy. Each patient’s story has the unique potential to teach us something new about the way cancer works, and help us find more effective treatments, faster.
At Flatiron, we believe that learning from the experience of every cancer patient is an imperative — it is the key to accelerating research and continuing to improve the quality of care. What stands in the way is an overwhelming technology challenge: Much of the available, real-world clinical data is unstructured and stored across thousands of disconnected community clinics, medical centers and hospitals. It is a problem that we believe we can solve.
Flatiron Health is a healthtech company dedicated to improving cancer treatment and advancing research. As the pioneer in real-world evidence for oncology, we provide technology and services to support patient care and make every patient story count. We partner with hundreds of cancer centers, 20+ top global developers of oncology therapeutics, and researchers and regulators around the world.
Founded in 2012, Flatiron became an independent affiliate of the Roche Group in 2018. Under the new leadership of CEO Carolyn Starrett in 2021, we’ve expanded our commitment to advance research and treatment for patients around the globe. Flatiron International subsidiaries in Japan, Germany and the United Kingdom will partner with hospitals and health networks in collaborations tailored to each market’s needs and legal, regulatory and compliance requirements.